Frontiers in Neurology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 19, 2024
A
78-year-old
man
with
dementia
experienced
waxing
and
waning
of
symptoms
changes
in
altitude
as
he
traveled
from
his
home
the
Rocky
Mountains
to
lower
elevations
back.
To
replicate
improvement
travel
(higher
pressure),
patient
was
treated
a
near-identical
repressurization
hyperbaric
chamber
using
compressed
air.
With
four
1-h
treatments
at
1.3
Atmospheres
Absolute
(ATA)
concurrent
administration
low-dose
oral
glutathione
amino
acid
precursors,
recovered
speech
showed
activities
daily
living.
Regional
broadcast
media
had
documented
novel
recovery.
Nosocomial
COVID-19
withdrawal
air
therapy
led
demise
7
months
after
initiation
treatment.
It
is
theorized
that
stimulated
mitochondrial
biochemical
physical
changes,
which
clinical
improvement.
GeroScience,
Год журнала:
2024,
Номер
46(3), С. 2885 - 2899
Опубликована: Фев. 23, 2024
Abstract
The
long
COVID
(coronavirus
disease),
a
multisystemic
condition
following
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
infection,
is
one
of
the
widespread
problems.
Some
its
symptoms
affect
nervous
system
and
resemble
Alzheimer’s
disease
(AD)—a
neurodegenerative
caused
by
accumulation
amyloid
beta
hyperphosphorylation
tau
proteins.
Multiple
studies
have
found
dependence
between
these
two
conditions.
Patients
with
greater
risk
SARS-CoV-2
infection
due
to
increased
levels
angiotensin-converting
enzyme
2
(ACE2),
itself
promotes
generation
which
enhances
AD.
Also,
molecular
pathways
are
alike—misregulations
in
folate-mediated
one-carbon
metabolism,
deficit
Cq10,
disease-associated
microglia.
Medical
imaging
both
diseases
shows
decrease
volume
gray
matter,
global
brain
size
reduction,
hypometabolism
parahippocampal
gyrus,
thalamus,
cingulate
cortex.
In
some
studies,
similar
approach
applied
medication
can
be
seen,
including
use
amino
adamantanes
phenolic
compounds
rosemary.
significance
connections
their
possible
application
medical
practice
still
needs
further
study
but
there
possibility
that
they
will
help
better
understand
COVID.
Aging and Disease,
Год журнала:
2024,
Номер
unknown, С. 0 - 0
Опубликована: Янв. 1, 2024
Neurodegenerative
diseases,
particularly
Alzheimer's
disease
and
other
dementias
as
well
Parkinson's
disease,
are
emerging
profoundly
significant
challenges
burdens
to
global
health,
a
trend
highlighted
by
the
most
recent
Global
Burden
of
Disease
(GBD)
2021
studies.
This
growing
impact
is
closely
linked
demographic
shift
toward
an
aging
population
potential
long-term
repercussions
COVID-19
pandemic,
both
which
have
intensified
prevalence
severity
these
conditions.
In
this
review,
we
explore
several
critical
aspects
complex
issue,
including
increasing
burden
neurodegenerative
unmet
medical
social
needs
within
current
care
systems,
unique
amplified
posed
strategies
for
enhancing
healthcare
policy
practice.
We
underscore
urgent
need
cohesive,
multidisciplinary
approaches
across
medical,
research,
domains
effectively
address
thereby
improving
quality
life
patients
their
caregivers.
QJM,
Год журнала:
2024,
Номер
117(10), С. 709 - 716
Опубликована: Май 26, 2024
Abstract
Background
The
challenges
of
the
COVID-19
pandemic
extend
to
concerns
about
vaccine
side
effects,
particularly
potential
links
neurodegenerative
diseases
such
as
Alzheimer’s
disease
(AD).
Aim
This
study
investigates
association
between
vaccination
and
onset
AD
its
prodromal
state,
mild
cognitive
impairment
(MCI).
Design
A
nationwide,
retrospective
cohort
leveraging
data
from
Korean
National
Health
Insurance
Service
was
conducted.
Methods
study,
conducted
in
Seoul,
South
Korea,
analyzed
a
random
50%
sample
city
residents
aged
65
above,
totaling
558
017
individuals.
Participants
were
divided
into
vaccinated
unvaccinated
groups,
with
vaccinations
including
mRNA
cDNA
vaccines.
focused
on
MCI
incidences
post-vaccination,
identified
via
ICD-10
codes,
using
multivariable
logistic
Cox
regression
analyses.
Patients
vascular
dementia
or
Parkinson’s
served
controls.
Results
Findings
showed
an
increased
incidence
individuals,
those
receiving
vaccines,
within
three
months
post-vaccination.
group
exhibited
significantly
higher
(odds
ratio
[OR]:
1.225;
95%
confidence
interval
[CI]:
1.025–1.464;
P
=
0.026)
(OR:
2.377;
CI:
1.845–3.064;
<
0.001)
compared
group.
No
significant
relationship
found
disease.
Conclusions
Preliminary
evidence
suggests
link
vaccination,
MCI.
warrants
need
for
further
research
elucidate
vaccine-induced
immune
responses
processes,
advocating
continuous
monitoring
investigation
vaccines'
long-term
neurological
impacts.
Annals of Neurology,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 22, 2024
Objective
To
investigate
neurologic
manifestations
of
post‐acute
sequelae
SARS‐CoV‐2
infection
(Neuro‐PASC)
in
post‐hospitalization
Neuro‐PASC
(PNP)
and
non‐hospitalized
(NNP)
patients
across
the
adult
lifespan.
Methods
Cross‐sectional
study
first
consecutive
200
PNP
1,100
NNP
evaluated
at
a
Neuro‐coronavirus
disease
2019
(COVID‐19)
clinic
between
May
2020
March
2023.
Patients
were
divided
into
younger
(18–44
years),
middle‐age
(45–64
older
(65+
years)
age
groups.
Results
Younger
individuals
accounted
for
142
(71%)
995
1100
(90.5%)
patients.
Significant
age‐related
differences
frequencies
comorbidities
abnormal
findings
demonstrated
higher
prevalence
Conversely,
10
months
from
COVID‐19
onset,
we
found
significant
symptoms
indicating
lower
prevalence,
therefore,
symptom
burden,
individuals.
Moreover,
there
subjective
impression
fatigue
(median
[interquartile
range
(IQR)]
patient‐reported
outcomes
measurement
information
system
[PROMIS]
score:
64
[57–69],
63
[57–68],
60.5
[50.8–68.3];
p
=
0.04)
sleep
disturbance
[IQR]
PROMIS
57
[51–63],
56
[53–63],
54
[46.8–58];
0.002)
group,
commensurate
with
impairment
quality
life
(QoL)
among
Finally,
objective
executive
function
National
Institutes
Health
[NIH]
toolbox
48
[35–63],
49
[38–63],
54.5
[45–66.3];
0.01),
working
memory
NIH
47
[40–53],
50
[44–57],
[43–58];
0.0002)
patients,
worst
performance
coming
group.
Interpretation
are
disproportionally
affected
by
regardless
acute
severity.
Although
people
more
frequently
have
comorbidities,
suffer
burden
cognitive
dysfunction
contributing
to
decreased
QoL.
principally
affects
adults
their
prime,
profound
public
health
socioeconomic
impacts
warranting
dedicated
resources
prevention,
diagnosis
interventions.
ANN
NEUROL
2024
BACKGROUND
The
COVID-19
pandemic
requires
a
deep
understanding
of
SARS-CoV-2,
particularly
how
mutations
in
the
Spike
Receptor
Binding
Domain
(RBD)
Chain
E
affect
its
structure
and
function.
Current
methods
lack
comprehensive
analysis
these
at
different
structural
levels.
OBJECTIVE
To
analyze
impact
specific
associated
point
(N501Y,
L452R,
N440K,
K417N,
E484A)
on
SARS-CoV-2
RBD
function
using
predictive
modeling,
including
graph-theoretic
model,
protein
modeling
techniques,
molecular
dynamics
simulations.
METHODS
study
employed
multi-tiered
framework
to
represent
across
three
interconnected
This
model
incorporated
19
top-level
vertices,
connected
intermediate
graphs
based
6-angstrom
proximity
within
protein's
3D
structure.
Graph-theoretic
metrics
were
applied
weigh
vertices
edges
all
also
used
Iterative
Threading
Assembly
Refinement
(I-TASSER)
mutated
sequences
dynamic
simulation
(MD)
tools
evaluate
changes
folding
stability
compared
wildtype.
RESULTS
Three
distinct
analytical
approaches
successfully
identified
functional
(Chain
E)
resulting
from
mutations.
novel
detected
notable
changes,
with
N501Y
L452R
showing
most
pronounced
effects
conformation
stability.
K147N
E484A
demonstrated
less
significant
impacts.
Ab
initio
MD
findings
corroborated
analysis.
multi-level
approach
provided
visualization
mutation
effects,
deepening
our
their
consequences.
CONCLUSIONS
advanced
implications.
multi-faceted
characterized
various
mutations,
identifying
as
having
substantial
have
important
implications
for
vaccine
development,
therapeutic
design,
variant
monitoring.
research
underscores
power
combining
multiple
virology,
contributing
valuable
knowledge
ongoing
efforts
against
providing
future
studies
viral
impacts
Frontiers in Genetics,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 14, 2025
Since
host
genetics
is
one
of
the
primary
factors
contributing
to
COVID-19
susceptibility
and
its
clinical
progression,
several
studies
have
focused
on
analysing
implications
genetic
polymorphisms
associated
with
COVID-19.
These
particularly
emphasise
common
variants
in
genes
that
are
involved
viral
mechanism
entry
host’s
response
infection.
In
this
study,
we
explored
participation
24
single
nucleotide
located
ACE
,
ADAM17
FURIN
IFITM3
TMPRSS2
VDR
SARS-CoV-2
infection
susceptibility.
Three
these
SNPs
(rs75603675,
OR
=
1.86,
95%
CI
1.29–2.66,
p
≤
0.001;
rs4303795,
1.98,
1.38–2.84,
0.001
rs8134378,
2.59,
1.28–5.21,
0.01)
had
a
significant
association
an
increased
risk
When
comparing
haplotype
frequency
distributions,
haplotypes
CAG
(OR
7.34,
5.51–9.77),
AGA
2.46,
1.12–5.44),
AGG
1.59,
1.17–2.16)
presented
associations,
suggesting
influences
within
Mexican
Mestizos.
alleles
their
were
found
more
frequently
case
group
than
reference
group,
at
least
twofold
increase
infection,
finding
was
reinforced
by
meta-analyses.